Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-INSPIRe
PACTR202307490670785Phase 2Recruiting
- Sponsor
- Aerogen Pharma
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of calfactant in respiratory distress syndrome (RDS) (2 arms), sponsored by Aerogen Pharma. Started May 2023; status: recruiting.
02
Drugs
calfactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on PACTR202307490670785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202307490670785.